We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Meridian
MRBK
$237M
| $3.21M | 0.01% |
327,680
+5,662
| +2% | +$57.3K |
|
252
Lamar Advertising Co
LAMR
$16.1B
| $3.17M | 0.01% |
31,940
+6,950
| +28% | +$674K |
|
253
Helix Energy Solutions
HLX
$1.46B
| $3.14M | 0.01% |
425,000
-150,000
| -26% | -$1.07M |
|
254
Assurant
AIZ
$13.6B
| $3.09M | 0.01% |
24,590
-210
| -0.8% | -$26.1K |
|
255
nVent Electric
NVT
$24.9B
| $3.08M | 0.01% |
59,661
-10,000
| -14% | -$444K |
|
256
Blackstone
BX
$100B
| $2.8M | 0.01% |
30,139
+2,656
| +10% | +$229K |
|
257
Kimberly-Clark
KMB
$35.9B
| $2.8M | 0.01% |
20,260
-71,941
| -78% | -$10M |
|
258
Baxter International
BAX
$11.5B
| $2.77M | 0.01% |
60,893
-39,265
| -39% | -$1.71M |
|
|
ESGR
259
DELISTED
Enstar Group
ESGR
| $2.77M | 0.01% |
11,347
-145
| -1% | -$35.8K |
|
260
CF Bankshares
CFBK
$214M
| $2.77M | 0.01% |
184,519
+7,500
| +4% | +$124K |
|
261
Salesforce
CRM
$132B
| $2.76M | 0.01% |
13,046
-228
| -2% | -$46.5K |
|
262
Crinetics Pharmaceuticals
CRNX
$8.86B
| $2.74M | 0.01% |
152,200
| – | – |
|
263
Applied Materials
AMAT
$433B
| $2.71M | 0.01% |
18,728
-443
| -2% | -$55.4K |
|
264
Black Hills Corp
BKH
$5.74B
| $2.66M | 0.01% |
44,172
-9,000
| -17% | -$571K |
|
265
Air Products & Chemicals
APD
$65.8B
| $2.64M | 0.01% |
8,798
-799
| -8% | -$228K |
|
266
Corteva
CTVA
$59.1B
| $2.63M | 0.01% |
45,931
-3,674
| -7% | -$214K |
|
267
4D Molecular Therapeutics
FDMT
$526M
| $2.61M | 0.01% |
+144,492
| New | +$2.66M |
|
268
Graphic Packaging
GPK
$3.18B
| $2.59M | 0.01% |
107,858
-4,300
| -4% | -$108K |
|
269
Adobe
ADBE
$87.1B
| $2.56M | 0.01% |
5,228
-217
| -4% | -$87.4K |
|
270
M&T Bank
MTB
$35.8B
| $2.48M | 0.01% |
20,006
-2,312
| -10% | -$280K |
|
|
GLDD
271
DELISTED
Great Lakes Dredge & Dock
GLDD
| $2.45M | 0.01% |
300,000
| – | – |
|
272
Lockheed Martin
LMT
$134B
| $2.41M | 0.01% |
5,238
-2
| -0% | -$928 |
|
|
KW
273
DELISTED
Kennedy-Wilson Holdings
KW
| $2.4M | 0.01% |
147,150
-7,100
| -5% | -$113K |
|
274
eBay
EBAY
$48.1B
| $2.39M | 0.01% |
53,378
-9,650
| -15% | -$428K |
|
275
State Street Blackstone Senior Loan ETF
SRLN
$5.3B
| $2.37M | 0.01% |
56,628
-4,700
| -8% | -$194K |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.